Drug Trial Radar · NCT06562543
A Trial to Evaluate the Safety and Activity of Fruquintinib in Minority Populations With Advanced, Previously Treated Colorectal Cancer
Last checked: Nov 20, 2026Latest source record: Jul 7, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
78
Planned (sponsor's estimate)
Start
Jan 14, 2025
Primary completion
Oct 4, 2027
Study completion Oct 4, 2027
Sponsor
- Lead sponsor
- TakedaTakeda (TAK)
- Sponsor type
- Industry
- First posted
- Aug 20, 2024
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
High blood pressure (hypertension) is a known side effect of the treatment with fruquintinib. Current research does not provide a clear answer whether minority groups such as Black/African American and/or Hispanic/Latino with refractory metastatic colorectal cancer (mCRC) have a bigger risk of higher blood pressure after treatment with fruquintinib. The main aim of this study is to learn how often adults of a minority group experience hypertension after they have been treated with fruquintinib for refractory mCRC. Other aims are to learn how safe fruquintinib is and how well it is tolerated by participants. Participants will receive fruquintinib in 4-week treatment cycles until their condition worsens, they do no longer tolerate the treatment or stop the treatment for other reasons. After the last treatment, participants will be checked upon every 3 months until study completion.
Conditions
- Colorectal Cancer
Interventions
FruquintinibDrug
Oral capsules
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of Participants with Treatment Emergent Grade 3 and Grade 4 HypertensionTime frame: From the first dose of the study drug up to end of study (approximately 35 months)
Locations
45 sites in 2 countries. Site status is shown where the registry gives one.
Central Alabama Research
Birmingham, Alabama · Recruiting
University of Alabama at Birmingham
Birmingham, Alabama · Recruiting
Ironwood Cancer and Research Centers
Chandler, Arizona · Recruiting
University of Arizona
Tucson, Arizona · Recruiting
University of California San Diego
La Jolla, California · Recruiting
University of Southern California
Los Angeles, California · Recruiting
PIH Health Whittier Hospital
Whittier, California · Recruiting
Christiana Care Health Services
Newark, Delaware · Recruiting
University of Florida
Gainesville, Florida · Completed
University of Miami
Miami, Florida · Withdrawn
Baptist Health - Miami Cancer Institute
Miami, Florida · Withdrawn
Emory University
Atlanta, Georgia · Recruiting
Hope and Healing Cancer Services
Hinsdale, Illinois · Recruiting
Indiana University
Indianapolis, Indiana · Recruiting
Our Lady of the Lake Physician Group - LSU Health Baton Rouge Oncology
Baton Rouge, Louisiana · Recruiting
Willis Knighton Cancer Center
Shreveport, Louisiana · Recruiting
Mercy Medical Center
Baltimore, Maryland · Recruiting
Boston Medical Center
Boston, Massachusetts · Withdrawn
Hattiesburg Clinic
Hattiesburg, Mississippi · Recruiting
Saint Luke's Cancer Institute
Kansas City, Missouri · Withdrawn
Midwest Oncology Associates - Kansas City
Kansas City, Missouri · Recruiting
SSM Health St. Louis DePaul Hospital
St Louis, Missouri · Recruiting
Washington University School of Medicine
St Louis, Missouri · Recruiting
Capital Health Medical Center - Hopewell
Pennington, New Jersey · Recruiting
Columbia University
New York, New York · Withdrawn
Albert Einstein College of Medicine
The Bronx, New York · Withdrawn
James J Peters Veterans Administration Medical Center - NAVREF
The Bronx, New York · Withdrawn
Zangmeister Cancer Center
Columbus, Ohio · Recruiting
Hightower Clinical Research
Oklahoma City, Oklahoma · Completed
Jefferson Health
Philadelphia, Pennsylvania · Recruiting
Fox Chase Cancer Center | Philadelphia, PA
Philadelphia, Pennsylvania · Withdrawn
Medical University of South Carolina
Charleston, South Carolina · Withdrawn
University of Tennessee -- Memphis
Memphis, Tennessee · Recruiting
Vanderbilt University Medical Center
Nashville, Tennessee · Recruiting
University of Texas Southwestern Medical Center
Dallas, Texas · Recruiting
Renovatio Clinical
El Paso, Texas · Recruiting
Oncology Consultants - Memorial City Location
Houston, Texas · Recruiting
Baylor College of Medicine
Houston, Texas · Recruiting
BRCR Global
Katy, Texas · Withdrawn
Renovatio Clinical
The Woodlands, Texas · Recruiting
Showing 40 of 45 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.